Case number 1:18-cv-00247
Pharmacyclics LLC et al v. Cipla Limited et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| May 3, 2021 | N/A | Terminated Case (0) Docket Text: CASE CLOSED per D.I. [559] in Lead CA No. 18-192-CFC/CJB. (fms) |
| Feb 19, 2019 | 45 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Cipla's [CONFIDENTIAL] Objections and Responses to Plaintiffs' First Set of Interrogatories (Nos. 1-8); and (2) Cipla's [CONFIDENTIAL] Objections and Responses to Plaintiffs' Second Set of Requests (Nos. 12-80) to Cipla Limited and Cipla USA Inc. for the Production of Documents and Things filed by Cipla Limited, Cipla USA Inc..(Bilson, David) |
| Nov 26, 2018 | N/A | Create Case Association (0) Docket Text: Case associated with lead case: Create association to 1:18-cv-00192-CFC. ALL FUTURE FILINGS are to be made in Lead Case No. 18-cv-192-CFC. (nmf) |
| Nov 26, 2018 | N/A | Oral Order (0) Docket Text: ORAL ORDER: Whereas the Court directed the parties during the October 17, 2018 hearing to file a proposed scheduling order using the Court's form order and whereas the parties have not done so, it is hereby ORDERED that the parties shall file by no later than November 29, 2018 a proposed scheduling order using the Court's form order (revised as of November 14, 2018) that incorporates the dates and discovery limitations currently in effect. It is further ORDERED that for all purposes other than trial, these cases are to be treated as consolidated and all filings are to be made in Lead Case No. 18-192-CFC. Signed by Judge Colm F. Connolly on 11/26/2018. Associated Cases: 1:18-cv-00192-CFC, 1:18-cv-00237-CFC, 1:18-cv-00247-CFC, 1:18-cv-00275-CFC(nmf) |
| Nov 2, 2018 | 44 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Defendants' Initial Invalidity Contentions filed by Fresenius Kabi Oncology Limited, Fresenius Kabi USA, LLC.(Farnan, Brian) |
| Oct 30, 2018 | 43 | Protective Order (30) Docket Text: PROTECTIVE ORDER. Signed by Judge Colm F. Connolly on 10/29/2018. Associated Cases: 1:18-cv-00192-CFC, 1:18-cv-00237-CFC, 1:18-cv-00247-CFC, 1:18-cv-00275-CFC(fms) |
| Oct 26, 2018 | 42 | Proposed Order (30) Docket Text: PROPOSED ORDER // Protective Order by Janssen Biotech, Inc., Pharmacyclics LLC, Janssen Biotech Inc.. (Tigan, Jeremy) |
| Oct 22, 2018 | 41 | Notice of Service (7) Docket Text: NOTICE OF SERVICE of Plaintiffs' Responses to Defendants' First Set of Joint Interrogatories (Nos. 1-4) filed by Janssen Biotech, Inc., Pharmacyclics LLC, Janssen Biotech Inc..(Tigan, Jeremy) |
| Oct 18, 2018 | N/A | Oral Order (0) Docket Text: ORAL ORDER, Having reviewed the parties' submissions and heard oral argument relating to two disputes over the otherwise agreed-upon protective order (PO) in Civil Actions 18-192-CFC, 18-237-CFC, 18-247-CFC, and 18-275-CFC, IT IS HEREBY ORDERED that Defendants proposal with respect to paragraphs 19 and 20 of the contemplated PO, which would prohibit Plaintiffs from disclosing confidential information (CI) produced to Plaintiffs in discovery by any one Defendant to the outside counsel and experts of any other Defendant without first obtaining the producing Defendants consent, is REJECTED for the reasons stated by the Court and made clear by the Courts questioning of the parties at oral argument on October 17, 2018. The Court further notes that its decision was informed by the following: (1) this action is one of four actions that have been effectively consolidated for pre-trial purposes with a single schedule (including a consolidated Markman hearing) and common discovery; (2) Plaintiffs have proposed a reasonable alternative to Defendants' proposal that would limit the cross-disclosure of CI to Defendants' outside counsel and experts; (3) Defendants agree that their outside counsel are not competitive decision makers and are subject to an agreed-upon prosecution bar in the contemplated PO; (4) the deadline for the parties to identify their respective experts affords each Defendant sufficient time to seek Court intervention in the event a Defendant believes (i) an identified expert is a competitive decision maker or should be subject to the PO's prosecution bar, and/or (ii) good cause exists to prohibit the expert in question from having access to a Defendants CI; (5) Defendants' proposal would place an undue, unfair, and unnecessary burden on Plaintiffs; (6) Defendants' proposal would lead to significant disruptions in discovery, depositions, and court proceedings and would impose an undue burden on the Court; and (7) Defendants have not demonstrated that restrictions beyond Plaintiffs' proposed alternative are necessary to avoid the risk that a co-Defendant would use a producing Defendants' CI's to the competitive disadvantage of the producing Defendant. Ordered by Judge Colm F. Connolly on 10/18/2018. Associated Cases: 1:18-cv-00192-CFC, 1:18-cv-00237-CFC, 1:18-cv-00247-CFC, 1:18-cv-00275-CFC(nmf) |
| Oct 18, 2018 | N/A | Oral Order (0) Docket Text: ORAL ORDER, Having reviewed the parties' submissions and heard oral argument relating to two disputes over the otherwise agreed-upon protective order (PO) in Civil Actions 18-192-CFC, 18-237-CFC, 18-247-CFC, and 18-275-CFC, IT IS HEREBY ORDERED that Defendant Cipla's request that a non-attorney outside the United States be given access to Plaintiffs confidential information (CI) is REJECTED. The Court notes that it misspoke at the October 17, 2018 oral argument to the extent its remarks suggested that Cipla was required to demonstrate good cause that the non-attorney should be given access to Plaintiffs' CI. On the contrary, the Court understood and understands that the burden to persuade the Court to limit access to Plaintiffs' discovery productions rests with Plaintiffs. In this case, Plaintiffs' submission (D.I. 40) persuaded the Court that good cause exists to prohibit the non-attorney in question from having access to Plaintiffs CI. The Court notes that its decision to reject Cipla's request was informed by the following: (1) Plaintiffs have legitimate concerns that disclosure of their CI could injure them in significant ways and their proposal to limit the disclosure of their CI to Ciplas outside counsel, experts, and two of Cipla's in-house attorneys is a reasonable proposal that balances their confidentiality concerns with Cipla's ability to defend itself in this action; (2) Cipla does not dispute that the job title of the non-attorney in question is Patent Portfolio Management; (3) Cipla acknowledges that the individual in question has the most intimate day-to-day knowledge of the ibrutinib project (D.I. 39 at 3); (4) as a non-attorney, the individual in question is not subject to the professional and ethical obligations that attorneys are and would not be subject to the same sanctions an attorney would be if she failed to abide by the terms of the PO; and (5) Cipla has not demonstrated that limiting access of Plaintiffs CI to Ciplas two in-house attorneys would prejudice its ability to defend itself in this action. Ordered by Judge Colm F. Connolly on 10/18/2018. (nmf) |
| Oct 17, 2018 | N/A | Discovery Conference (0) Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - Discovery Conference held on 10/17/2018. (Court Reporter V. Gunning.) Associated Cases: 1:18-cv-00192-CFC, 1:18-cv-00237-CFC, 1:18-cv-00247-CFC, 1:18-cv-00275-CFC(nmf) |
| Oct 16, 2018 | 40 | Exhibits A-D (85) |
| Oct 16, 2018 | 40 | Letter (4) Docket Text: Letter to The Honorable Colm F. Connolly from Jeremy A. Tigan regarding the proposed Protective Order - re (45 in 1:18-cv-00192-CFC, 39 in 1:18-cv-00247-CFC, 57 in 1:18-cv-00237-CFC, 73 in 1:18-cv-00275-CFC) Letter. (Attachments: # (1) Exhibits A-D)(Tigan, Jeremy) |
| Oct 15, 2018 | 39 | Exhibit B (4) |
| Oct 15, 2018 | 39 | Exhibit A (37) |
| Oct 15, 2018 | 39 | Letter (7) Docket Text: Letter to The Honorable Colm F. Connolly from Dominick T. Gattuso regarding Opening Discovery Dispute Letter. (Attachments: # (1) Exhibit A, # (2) Exhibit B)(Gattuso, Dominick) |
| Oct 9, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (71 in 1:18-cv-00275-CFC, 44 in 1:18-cv-00192-CFC, 55 in 1:18-cv-00237-CFC) STIPULATION TO EXTEND TIME to EXTEND the deadline for Defendants' Initial Invalidity Contentions to 11/2/2018 filed by Fresenius Kabi USA, LLC, (38 in 1:18-cv-00247-CFC) STIPULATION TO EXTEND TIME to Extend Deadline for Initial Invalidity Contentions to November 2, 2018 filed by Cipla Limited, Cipla USA Inc.. Signed by Judge Colm F. Connolly on 10/9/2018. Associated Cases: 1:18-cv-00192-CFC, 1:18-cv-00237-CFC, 1:18-cv-00247-CFC, 1:18-cv-00275-CFC(fms) |
| Oct 5, 2018 | 38 | Stipulation to EXTEND Time (5) Docket Text: STIPULATION TO EXTEND TIME to Extend Deadline for Initial Invalidity Contentions to November 2, 2018 - filed by Cipla Limited, Cipla USA Inc.. (Bilson, David) |
| Oct 4, 2018 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Elizabeth J. Holland,Keith A. Zullow,Steven J. Bernstein for Cipla Limited, Cipla USA Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (crb) |
| Oct 3, 2018 | N/A | Set/Reset Hearings (0) Docket Text: Set Hearings: A Discovery Conference is set for 10/17/2018 at 11:00 AM per request of counsel in Courtroom 4B before Judge Colm F. Connolly. Associated Cases: 1:18-cv-00192-CFC, 1:18-cv-00237-CFC, 1:18-cv-00247-CFC, 1:18-cv-00275-CFC(nmf) |
| Oct 1, 2018 | 37 | Order (4) Docket Text: ORDER: IT IS ORDERED that on or before October 22, 2018, each party or each party group shall email to Chief Magistrate Judge Thynge, with a copy to her Judicial Administrator, Cathleen Kennedy, information requested regarding ADR. SEE ORDER FOR DETAILS. Signed by Judge Mary Pat Thynge on 10/1/18. Associated Cases: 1:18-cv-00192-CFC, 1:18-cv-00237-CFC, 1:18-cv-00247-CFC, 1:18-cv-00275-CFC(cak) |
| Sep 20, 2018 | N/A | Case Reassigned to CFC (0) Docket Text: Case reassigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. Associated Cases: 1:18-cv-00192-CFC, 1:18-cv-00237-CFC, 1:18-cv-00247-CFC, 1:18-cv-00275-CFC (rjb) |
| Sep 7, 2018 | 36 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Fresenius Kabi's, Zydus's, Sun's, Cipla's and Teva's First Set of Joint Interrogatories to Plaintiffs (Nos. 1-4) filed by Fresenius Kabi Oncology Limited, Fresenius Kabi USA, LLC.(Farnan, Brian) |
| Sep 5, 2018 | 35 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Initial Infringement Contentions filed by Janssen Biotech, Inc., Pharmacyclics LLC.(Blumenfeld, Jack) |
| Sep 5, 2018 | 34 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' [CONFIDENTIAL-OUTSIDE ATTORNEYS' EYES ONLY] Objections and Responses to Plaintiffs' First Set of Requests (Nos. 1-11) to Cipla Limited and Cipla USA Inc. for the Production of Documents and Things filed by Cipla Limited, Cipla USA Inc..(Bilson, David) |
| Aug 29, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED - re (33 in 1:18-cv-00247-GMS, 59 in 1:18-cv-00275-GMS, 37 in 1:18-cv-00192-GMS, 48 in 1:18-cv-00237-GMS) STIPULATION TO EXTEND TIME for the parties to submit their Protective Order to September 7, 2018 filed by Janssen Biotech, Inc., Pharmacyclics LLC. Ordered by Judge Gregory M. Sleet on 8/29/2018. Associated Cases: 1:18-cv-00192-GMS, 1:18-cv-00237-GMS, 1:18-cv-00247-GMS, 1:18-cv-00275-GMS(mdb) |
| Aug 27, 2018 | 33 | Stipulation to EXTEND Time (5) Docket Text: STIPULATION TO EXTEND TIME for the parties to submit their Protective Order to September 7, 2018 - filed by Janssen Biotech, Inc., Pharmacyclics LLC. (Blumenfeld, Jack) |
| Aug 22, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED - re (31 in 1:18-cv-00247-GMS, 57 in 1:18-cv-00275-GMS, 46 in 1:18-cv-00237-GMS, 35 in 1:18-cv-00192-GMS) STIPULATION TO EXTEND TIME for the parties to submit their protective order to August 20, 2018 filed by Janssen Biotech Inc., Janssen Biotech, Inc., Pharmacyclics LLC, (58 in 1:18-cv-00275-GMS, 32 in 1:18-cv-00247-GMS, 36 in 1:18-cv-00192-GMS, 47 in 1:18-cv-00237-GMS) STIPULATION TO EXTEND TIME for the parties to submit their Protective Order to August 27, 2018 filed by Janssen Biotech Inc., Janssen Biotech, Inc., Pharmacyclics LLC. Ordered by Judge Gregory M. Sleet on 8/22/2018. Associated Cases: 1:18-cv-00192-GMS, 1:18-cv-00237-GMS, 1:18-cv-00247-GMS, 1:18-cv-00275-GMS(mdb) |
| Aug 20, 2018 | 32 | Stipulation to EXTEND Time (5) Docket Text: STIPULATION TO EXTEND TIME for the parties to submit their Protective Order to August 27, 2018 - filed by Janssen Biotech, Inc., Pharmacyclics LLC, Janssen Biotech Inc.. (Blumenfeld, Jack) |
| Aug 13, 2018 | 31 | Stipulation to EXTEND Time (5) Docket Text: STIPULATION TO EXTEND TIME for the parties to submit their protective order to August 20, 2018 - filed by Janssen Biotech, Inc., Pharmacyclics LLC, Janssen Biotech Inc.. (Blumenfeld, Jack) |
| Aug 6, 2018 | 30 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' First Set of Requests (Nos. 1-11) to Cipla Limited and Cipla USA Inc. for the Production of Documents and Things filed by Janssen Biotech, Inc., Pharmacyclics LLC.(Blumenfeld, Jack) |
| Jul 31, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED - re (55 in 1:18-cv-00275-GMS, 44 in 1:18-cv-00237-GMS, 29 in 1:18-cv-00247-GMS, 33 in 1:18-cv-00192-GMS) STIPULATION TO EXTEND TIME for the parties to submit the Protective Order to August 13, 2018 filed by Janssen Biotech, Inc., Pharmacyclics LLC. Ordered by Judge Gregory M. Sleet on 7/31/2018. Associated Cases: 1:18-cv-00192-GMS, 1:18-cv-00237-GMS, 1:18-cv-00247-GMS, 1:18-cv-00275-GMS(mdb) |
| Jul 27, 2018 | 29 | Stipulation to EXTEND Time (5) Docket Text: STIPULATION TO EXTEND TIME for the parties to submit the Protective Order to August 13, 2018 - filed by Janssen Biotech, Inc., Pharmacyclics LLC. (Noreika, Maryellen) |
| Jul 20, 2018 | N/A | Case Referred to Mediation (0) Docket Text: CASE REFERRED to Chief Magistrate Judge Thynge for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at http://www.ded.uscourts.gov/general-orders/magistrate-judges-standing-order-adr-mediation Associated Cases: 1:18-cv-00192-GMS, 1:18-cv-00237-GMS, 1:18-cv-00247-GMS, 1:18-cv-00275-GMS(fms) |
| Jun 29, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED - re (40 in 1:18-cv-00237-GMS, 28 in 1:18-cv-00247-GMS, 48 in 1:18-cv-00275-GMS, 32 in 1:18-cv-00192-GMS) Proposed Scheduling Order: Cases referred to the Magistrate Judge for the purpose of exploring ADR. (Motions for Joinder of Parties and to Amended Pleadings due by 8/16/2019., Claim Construction Opening Briefs due by 3/15/2019., Claim Construction Answering Briefs due by 4/19/2019., A Markman Hearing (full day) is set for 5/20/2019 at 09:30 AM in Courtroom 4A., Fact Discovery completed by 11/15/2019., Opening Expert Reports due by 2/7/2020., Rebuttal Expert Reports due by 3/27/2020., Expert Discovery due by 5/22/2020., A Status Telephone Conference is set for 3/9/2020 at 10:00 AM to discuss the length of trial and consolidation., Proposed Final Pretrial Order due by 7/31/2020., A Final Pretrial Conference is set for 8/10/2020 at 10:00 AM in Courtroom 4A., A Bench Trial (Length TBD) is set for 9/14/2020 at 09:00 AM in Courtroom 4A. See Proposed Scheduling Order for more details). Ordered by Judge Gregory M. Sleet on 6/29/2018. Associated Cases: 1:18-cv-00192-GMS, 1:18-cv-00237-GMS, 1:18-cv-00247-GMS, 1:18-cv-00275-GMS(mdb) |
| Jun 28, 2018 | 28 | Letter to The Honorable Gregory M. Sleet (1) |
| Jun 28, 2018 | 28 | Proposed Order (8) Docket Text: PROPOSED ORDER -- Scheduling Order -- by Janssen Biotech, Inc., Pharmacyclics LLC, Janssen Biotech Inc.. (Attachments: # (1) Letter to The Honorable Gregory M. Sleet)(Blumenfeld, Jack) |
| Jun 19, 2018 | 27 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Cipla Limited and Cipla USA, Inc.'s Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery filed by Cipla Limited, Cipla USA Inc..(Bilson, David) |
| Jun 18, 2018 | 26 | Notice of Service (11) Docket Text: NOTICE OF SERVICE of Plaintiffs' Paragraph 3 Initial Disclosures filed by Janssen Biotech, Inc., Pharmacyclics LLC, Janssen Biotech Inc..(Blumenfeld, Jack) |
| Jun 15, 2018 | 25 | Transcript (19) Docket Text: Official Transcript of Telephone Conference held on 06 14 18 before Judge Sleet. Court Reporter/Transcriber Maurer. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 7/6/2018. Redacted Transcript Deadline set for 7/16/2018. Release of Transcript Restriction set for 9/13/2018. (kjm) |
| Jun 14, 2018 | N/A | Telephone Conference (0) Docket Text: Minute Entry for proceedings held before Judge Gregory M. Sleet - Telephone Scheduling Conference held on 6/14/2018. The court assigned the following deadlines: The Markman Hearing (full day) is set for 5/20/2019 at 9:30 AM in Courtroom 4A; a Telephone Conference, to discuss the length of trial and consolidation, is set for 3/9/2020 at 10:00 AM; the Final Proposed Pretrial Order is due by the close of business on 7/31/2020; the Final Pretrial Conference is set for 8/10/2020 at 10:00 AM in Courtroom 4A; and the Bench Trial (length TBD) is set for 9/14/2020 at 9:00 AM in Courtroom 4A. The cases are referred to the Magistrate Judge for exploring ADR. An amended proposed scheduling order is due by 6/28/2018. The parties shall work out the rest of the schedule, given the dates and orders provided. (Court Reporter Kevin Maurer.) Associated Cases: 1:18-cv-00192-GMS, 1:18-cv-00237-GMS, 1:18-cv-00247-GMS, 1:18-cv-00275-GMS(mdb) Modified on 6/14/2018 (mdb). |
| Jun 14, 2018 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The Minute Entry dated today has been corrected to reflect that the Final Pretrial Conference is set for 8/10/2020 at 10:00 AM in Courtroom 4A. Associated Cases: 1:18-cv-00192-GMS, 1:18-cv-00237-GMS, 1:18-cv-00247-GMS, 1:18-cv-00275-GMS(mdb) |
| Jun 6, 2018 | N/A | Oral Order (0) Docket Text: ORAL ORDER re (31 in 1:18-cv-00237-GMS, 37 in 1:18-cv-00275-GMS, 26 in 1:18-cv-00192-GMS, 22 in 1:18-cv-00247-GMS) Joint Status Report - A Scheduling Telephone Conference is set for 6/14/2018 at 02:00 PM before Judge Gregory M. Sleet. The plaintiffs shall arrange the call and contact Chambers at (32) 573-4559 once all parties are on the line. Ordered by Judge Gregory M. Sleet on 6/6/2018. Associated Cases: 1:18-cv-00192-GMS, 1:18-cv-00237-GMS, 1:18-cv-00247-GMS, 1:18-cv-00275-GMS(mdb) |
| Jun 5, 2018 | 23 | Notice of Service (12) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs Pharmacyclics LLC and Janssen Biotech, Inc.'s Initial Disclosures Pursuant to Rule 26(a)(1) and (2) Plaintiffs Pharmacyclics LLC and Janssen Biotech, Inc.'s Identification of Accused Products and Asserted Patents filed by Pharmacyclics LLC, Janssen Biotech Inc..(Blumenfeld, Jack) |
| Jun 5, 2018 | 24 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Cipla Limited and Cipla USA, Inc.'s Initial Disclosures Pursuant to Rule 26(a)(1) filed by Cipla Limited, Cipla USA Inc..(Bilson, David) |
| May 25, 2018 | 22 | Status Report (19) Docket Text: Joint STATUS REPORT by Janssen Biotech, Inc., Pharmacyclics LLC. (Attachments: # (1) Proposed Schedulng Order)(Blumenfeld, Jack) |
| May 25, 2018 | 22 | Proposed Schedulng Order (10) |
| May 24, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED - re (35 in 1:18-cv-00275-GMS, 25 in 1:18-cv-00192-GMS, 29 in 1:18-cv-00237-GMS, 21 in 1:18-cv-00247-GMS) STIPULATION TO EXTEND TIME for the parties to submit the joint status report and proposed scheduling order to May 25, 2018 filed by Janssen Biotech Inc., Janssen Biotech, Inc., Pharmacyclics LLC. Ordered by Judge Gregory M. Sleet on 5/24/2018. Associated Cases: 1:18-cv-00192-GMS, 1:18-cv-00237-GMS, 1:18-cv-00247-GMS, 1:18-cv-00275-GMS(mdb) |
| May 22, 2018 | 21 | Stipulation to EXTEND Time (7) Docket Text: STIPULATION TO EXTEND TIME for the parties to submit the joint status report and proposed scheduling order to May 25, 2018 - filed by Janssen Biotech, Inc., Pharmacyclics LLC, Janssen Biotech Inc.. (Noreika, Maryellen) |
| May 18, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED - re (28 in 1:18-cv-00237-GMS, 24 in 1:18-cv-00192-GMS, 33 in 1:18-cv-00275-GMS, 20 in 1:18-cv-00247-GMS) MOTION for Pro Hac Vice Appearance of Attorney Nicole A. Conlon filed by Janssen Biotech Inc., Janssen Biotech, Inc., Pharmacyclics LLC. Ordered by Judge Gregory M. Sleet on 5/18/2018. Associated Cases: 1:18-cv-00192-GMS, 1:18-cv-00237-GMS, 1:18-cv-00247-GMS, 1:18-cv-00275-GMS(mdb) |
| May 17, 2018 | 20 | Motion for Leave to Appear Pro Hac Vice (7) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Nicole A. Conlon - filed by Janssen Biotech, Inc. (Noreika, Maryellen) Modified on 5/17/2018 (ceg). |
| May 16, 2018 | 19 | Answer to Counterclaim (24) Docket Text: ANSWER to [14] Answer to Complaint, Counterclaim by Janssen Biotech, Inc., Pharmacyclics LLC.(Noreika, Maryellen) |
| May 15, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED - re (26 in 1:18-cv-00237-GMS, 18 in 1:18-cv-00247-GMS, 30 in 1:18-cv-00275-GMS, 23 in 1:18-cv-00192-GMS) STIPULATION TO EXTEND TIME for the parties to submit the Joint Status Report and proposed scheduling order to May 22, 2018 filed by Janssen Biotech Inc., Janssen Biotech, Inc., Pharmacyclics LLC. Ordered by Judge Gregory M. Sleet on 5/15/2018. Associated Cases: 1:18-cv-00192-GMS, 1:18-cv-00237-GMS, 1:18-cv-00247-GMS, 1:18-cv-00275-GMS(mdb) |
| May 14, 2018 | 18 | Stipulation to EXTEND Time (6) Docket Text: STIPULATION TO EXTEND TIME for the parties to submit the Joint Status Report and proposed scheduling order to May 22, 2018 - filed by Janssen Biotech, Inc., Pharmacyclics LLC, Janssen Biotech Inc.. (Blumenfeld, Jack) |
| Apr 26, 2018 | 17 | Order (2) Docket Text: ORDER REGARDING CASE MANAGEMENT IN CIVIL CASES. Signed by Judge Gregory M. Sleet on 4/26/2018. (asw) |
| Apr 26, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED - re [16] MOTION for Pro Hac Vice Appearance of Attorney Elizabeth J. Holland, Keith A. Zullow, Steven J. Bernstein and Anjali Moorthy filed by Cipla Limited, Cipla USA Inc.. Ordered by Judge Gregory M. Sleet on 4/26/2018. (mdb) |
| Apr 25, 2018 | 16 | Certification of Steven J. Bernstein (1) |
| Apr 25, 2018 | 16 | Certification of Keith A. Zullow (1) |
| Apr 25, 2018 | 16 | Certification of Elizabeth J. Holland (1) |
| Apr 25, 2018 | 16 | Certification of Anjali Moorthy (1) |
| Apr 25, 2018 | 15 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Cipla Limited, Cipla USA Inc.. (Phillips, John) |
| Apr 25, 2018 | 14 | Answer to Complaint (30) Docket Text: ANSWER to [1] Complaint, Affirmative Defenses, COUNTERCLAIM against All Plaintiffs by Cipla USA Inc., Cipla Limited.(Phillips, John) Modified on 4/26/2018 (mdb). |
| Apr 25, 2018 | 16 | Motion for Leave to Appear Pro Hac Vice (1) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Elizabeth J. Holland, Keith A. Zullow, Steven J. Bernstein and Anjali Moorthy - filed by Cipla Limited, Cipla USA Inc.. (Attachments: # (1) Certification of Elizabeth J. Holland, # (2) Certification of Keith A. Zullow, # (3) Certification of Steven J. Bernstein, # (4) Certification of Anjali Moorthy)(Bilson, David) |
| Apr 13, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED - re (22 in 1:18-cv-00192-GMS, 25 in 1:18-cv-00275-GMS, 20 in 1:18-cv-00237-GMS, 13 in 1:18-cv-00247-GMS) STIPULATION TO EXTEND TIME to Submit Joint Status Report and Proposed Scheduling Order to May 15, 2018 filed by Janssen Biotech Inc., Janssen Biotech, Inc., Pharmacyclics LLC. Ordered by Judge Gregory M. Sleet on 4/13/2018. Associated Cases: 1:18-cv-00192-GMS, 1:18-cv-00237-GMS, 1:18-cv-00247-GMS, 1:18-cv-00275-GMS(mdb) |
| Apr 12, 2018 | 13 | Stipulation to EXTEND Time (9) Docket Text: STIPULATION TO EXTEND TIME to Submit Joint Status Report and Proposed Scheduling Order to May 15, 2018 - filed by Janssen Biotech, Inc., Pharmacyclics LLC, Janssen Biotech Inc.. (Blumenfeld, Jack) |
| Apr 11, 2018 | 12 | Motion for Leave to Appear Pro Hac Vice (10) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Gregory L. Diskant, Irena Royzman, Jordan M. Engelhardt, and Lachlan Campbell-Verduyn - filed by Janssen Biotech, Inc.. (Blumenfeld, Jack) |
| Apr 11, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED - re (21 in 1:18-cv-00192-GMS, 24 in 1:18-cv-00275-GMS, 12 in 1:18-cv-00247-GMS) MOTION for Pro Hac Vice Appearance of Attorney Gregory L. Diskant, Irena Royzman, Jordan M. Engelhardt, and Lachlan Campbell-Verduyn filed by Janssen Biotech, Inc.. Ordered by Judge Gregory M. Sleet on 4/11/2018. Associated Cases: 1:18-cv-00192-GMS, 1:18-cv-00247-GMS, 1:18-cv-00275-GMS(mdb) |
| Apr 5, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED - re (19 in 1:18-cv-00192-GMS, 11 in 1:18-cv-00247-GMS, 13 in 1:18-cv-00237-GMS, 20 in 1:18-cv-00275-GMS) MOTION for Pro Hac Vice Appearance of Attorney Christopher N. Sipes, Erica N. Andersen, Brianne Bharkhda, and Nicholas L. Evoy filed by Pharmacyclics LLC. Ordered by Judge Gregory M. Sleet on 4/5/2018. Associated Cases: 1:18-cv-00192-GMS, 1:18-cv-00237-GMS, 1:18-cv-00247-GMS, 1:18-cv-00275-GMS(mdb) |
| Apr 4, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED - re [10] STIPULATION TO EXTEND TIME to move, answer or otherwise respond to the Complaint to April 25, 2018 filed by Cipla Limited, Cipla USA Inc., Set/Reset Answer Deadlines: Cipla Limited answer due 4/25/2018; Cipla USA Inc. answer due 4/25/2018. Ordered by Judge Gregory M. Sleet on 4/4/2018. (mdb) |
| Apr 3, 2018 | 11 | Motion for Leave to Appear Pro Hac Vice (11) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Christopher N. Sipes, Erica N. Andersen, Brianne Bharkhda, and Nicholas L. Evoy - filed by Pharmacyclics LLC. (Blumenfeld, Jack) |
| Apr 2, 2018 | 10 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME to move, answer or otherwise respond to the Complaint to April 25, 2018 - filed by Cipla Limited, Cipla USA Inc.. (Phillips, John) |
| Mar 6, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED - re [9] STIPULATION TO EXTEND TIME to Answer, Move or Otherwise Respond to Complaint to April 4, 2018 filed by Cipla Limited, Cipla USA Inc., Set/Reset Answer Deadlines: Cipla Limited answer due 4/4/2018; Cipla USA Inc. answer due 4/4/2018.. Ordered by Judge Gregory M. Sleet on 3/6/2018. (mdb) |
| Mar 5, 2018 | 9 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME to Answer, Move or Otherwise Respond to Complaint to April 4, 2018 - filed by Cipla Limited, Cipla USA Inc.. (Phillips, John) |
| Feb 16, 2018 | 8 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Pharmacyclics LLC, Janssen Biotech, Inc.. Cipla USA Inc. served on 2/16/2018, answer due 3/9/2018. (Blumenfeld, Jack) |
| Feb 16, 2018 | 7 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Pharmacyclics LLC, Janssen Biotech, Inc.. Cipla Limited served on 2/14/2018, answer due 3/7/2018. (Blumenfeld, Jack) |
| Feb 14, 2018 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Gregory M. Sleet. Please include the initials of the Judge (GMS) after the case number on all documents filed. Associated Cases: 1:18-cv-00237-UNA, 1:18-cv-00247-UNA(nms) |
| Feb 13, 2018 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Cipla Limited on 2/13/2018; Cipla USA Inc. on 2/13/2018. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (nmg) |
| Feb 12, 2018 | 1 | Exhibit A-F (521) |
| Feb 12, 2018 | 6 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Johnson & Johnson for Janssen Biotech, Inc. filed by Janssen Biotech, Inc.. (nmg) |
| Feb 12, 2018 | 5 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent AbbVie Inc. for Pharmacyclics LLC filed by Pharmacyclics LLC. (nmg) |
| Feb 12, 2018 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,296,753 B2; 9,725,455 B1; 9,540,382 B2; 9,713,617 B2; 8,754,090 B2; 9,125,889 B2. (nmg) |
| Feb 12, 2018 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: Not earlier than 1/2/2018. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 5/13/2021. (nmg) |
| Feb 12, 2018 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmg) |
| Feb 12, 2018 | 1 | Civil Cover Sheet (1) |
| Feb 12, 2018 | 1 | Complaint* (1) |
